6/21/2024  5:42:59 PM Chg. 0.000 Volume Bid6/21/2024 Ask5:42:59 PM Market Capitalization Dividend Y. P/E Ratio
26.000EUR 0.00% 5.14 mill.
Turnover: 133.62 mill.
-Bid Size: - -Ask Size: - 25.65 bill.EUR 0.42% -

Business description

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
 

Management board & Supervisory board

CEO
Bill Anderson
Management board
Wolfgang Nickl, Heiko Schipper, Rodrigo Santos, Stefan Oelrich, Heike Prinz, Sebastian Guth
Supervisory board
Prof. Dr. Norbert Winkeljohann, Heike Hausfeld, Dr. Paul Achleitner, Dr. rer. nat. Simone Bagel-Trah, Horst Baier, Dr. Norbert W. Bischofberger, André van Broich, Ertharin Cousin, Yasmin Fahimi, Dr. Barbara Gansewendt, Colleen A. Goggins, Francesco Grioli, Frank Löllgen, Kimberly Mathisen, Andrea Sacher, Claudia Schade, Heinz Georg Webers, Alberto Weisser, Michael Westmeier, Prof. Dr. med. Dr. h.c. mult. Otmar D. Wiestler
 

Company data

Name: Bayer AG
Address: Kaiser-Wilhelm-Allee 1,D-51368 Leverkusen
Phone: +49-214-30-1
Fax: +49-214-30-81013
E-mail: info@bayer.com
Internet: www.bayer.de
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 12/31
Free Float: 68.44%
IPO date: 10/1/1953

Investor relations

Name: Oliver Maier
IR phone: +49-214-30-65742
IR Fax: +49-214-30-9665742
IR e-mail: oliver.maier@bayer.com

Company calendar

CW 32 | 8/6/2024 Interim Report 2nd Quarter/6 Months